Payers are increasingly integrating real-world evidence (RWE) into formulary decision-making, yet challenges remain in evaluating studies and aligning expectations. The AMCP Research Institute's RWE Initiative establishes industry standards to enhance communication and ensure effective use of RWE. This event provides insights into these standards, their application across drug lifecycles, and training efforts for managed care adoption.

Key Takeaways:

• The growing importance of RWE in pharma decision-making
• Collaborative development of RWE standards via expert consensus
• Practical guidance on implementing standardized RWE frameworks
• Ongoing initiatives to support payer adoption through training